278 related articles for article (PubMed ID: 15055914)
1. Treatment outcome in Turner syndrome.
Parvin M; Roche E; Costigan C; Hoey HM
Ir Med J; 2004 Jan; 97(1):12, 14-5. PubMed ID: 15055914
[TBL] [Abstract][Full Text] [Related]
2. [Optimizing estrogen treatment in Turner syndrome].
Ságodi L; Sólyom E
Orv Hetil; 2003 Mar; 144(12):563-8. PubMed ID: 12723527
[TBL] [Abstract][Full Text] [Related]
3. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
[TBL] [Abstract][Full Text] [Related]
4. [Turner syndrome: a virtually certain indication for growth hormone treatment].
Rongen-Westerlaken C; Wit JM
Tijdschr Kindergeneeskd; 1992 Oct; 60(5):155-63. PubMed ID: 1448805
[TBL] [Abstract][Full Text] [Related]
5. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
Menke LA; Sas TC; Visser M; Kreukels BP; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM; Cohen-Kettenis PT
Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349
[TBL] [Abstract][Full Text] [Related]
6. [Effect of estrogen therapy on the growth of Turner syndrome in girls treated with growth hormone].
Morin A; Guimarey L; Apezteguia M; Santucci Z
Medicina (B Aires); 2001; 61(3):271-4. PubMed ID: 11474872
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone therapy in Turner syndrome.
Davenport ML
Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():723-4. PubMed ID: 22946284
[TBL] [Abstract][Full Text] [Related]
8. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
Bareille P; Massarano AA; Stanhope R
Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
[TBL] [Abstract][Full Text] [Related]
10. Adult height in Turner Syndrome girls after long-term growth hormone treatment.
Morin A; Guimarey LM; Apezteguia M; Santucci ZC
Medicina (B Aires); 2009; 69(4):431-6. PubMed ID: 19770097
[TBL] [Abstract][Full Text] [Related]
11. Optimization of treatment in Turner's syndrome.
Gracia Bouthelier R; Oliver Iguacel A; Gonzalez Casado I; Alcalde de Alvaré A
J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():427-34. PubMed ID: 15134303
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone in turner syndrome.
Khadilkar VV; Khadilkar AV; Nandy M; Maskati GB
Indian Pediatr; 2006 Mar; 43(3):236-40. PubMed ID: 16585818
[TBL] [Abstract][Full Text] [Related]
13. Hormonal therapy in a patient with a delayed diagnosis of Turner's syndrome.
Gawlik A; Malecka-Tendera E
Nat Clin Pract Endocrinol Metab; 2008 Mar; 4(3):173-7. PubMed ID: 18227816
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
[TBL] [Abstract][Full Text] [Related]
15. Acceleration of growth in Turner syndrome patients treated with growth hormone: summary of three-year results.
Rosenfeld RG
J Endocrinol Invest; 1989; 12(8 Suppl 3):49-51. PubMed ID: 2681348
[TBL] [Abstract][Full Text] [Related]
16. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
17. The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome.
Collett-Solberg PF; Pessoa de Queiroz AN; Cardoso ME; Jusan RC; Vaisman M; Guimarães MM
Growth Horm IGF Res; 2006 Aug; 16(4):240-6. PubMed ID: 16908209
[TBL] [Abstract][Full Text] [Related]
18. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
Bannink EM; van Sassen C; van Buuren S; de Jong FH; Lequin M; Mulder PG; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
[TBL] [Abstract][Full Text] [Related]
19. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF; McNeill E; Young D; Donaldson MD
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[TBL] [Abstract][Full Text] [Related]
20. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
Stahnke N; Keller E; Landy H;
J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
